Bulletin
Investor Alert

Marker Therapeutics Inc.

NAS: MRKR

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209896576/composite

$

1.71

Change

0.00 0.00%

Volume

Volume 4,343

Sep 18, 2020, 5:24 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209896576/composite

Previous close

$ 1.71

$ 1.71

Change

0.00 0.00%

Day low

Day high

$1.66

$1.75

Open
Open: 1.75

52 week low

52 week high

$1.33

$6.10

Open

Market cap

$79.72M

Average volume

238,985

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.51

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrkr

MarketWatch News on MRKR

  1. How to invest in biotech stocks like a Nobel Prize winner

    11:47 a.m. Oct. 24, 2019

    - Michael Brush

  2. Resolute’s Resolve

    8:00 p.m. Oct. 26, 2018

    - Barron's Online

  3. TapImmune shares surge 17% on early-stage vaccine results

    8:31 a.m. March 15, 2018

    - Emma Court

  4. Tapimmune announces positive results in early-stage trial of treatment for ovarian and breast cancer

    8:04 a.m. March 15, 2018

    - Ciara Linnane

  5. TapImmune shares jump 24% premarket

    8:05 a.m. March 15, 2018

    - Ciara Linnane

Analyst Ratings

/news/nonmarketwatch/company/us/mrkr

Other News on MRKR

  1. Revisiting Marker Therapeutics

    11:00 a.m. June 7, 2020

    - Seeking Alpha

  2. GNFT, DT among premarket losers

    9:19 a.m. May 12, 2020

    - Seeking Alpha

  3. 10-Q: MARKER THERAPEUTICS, INC.

    4:26 p.m. May 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. AVEO, AVEO and CHK and PEI among midday movers

    12:41 p.m. April 30, 2020

    - Seeking Alpha

  5. OSTK, AR among premarket gainers

    9:20 a.m. April 30, 2020

    - Seeking Alpha

  6. Marker +20% as AML treatment is designated orphan drug

    6:29 p.m. April 29, 2020

    - Seeking Alpha

  7. Stocks To Watch: 0% To The Rescue?

    8:49 a.m. March 14, 2020

    - Seeking Alpha

  8. S, TMUS among premarket gainers

    10:18 a.m. Feb. 11, 2020

    - Seeking Alpha

  9. Gilead's Achilles' Heel - HIV Franchise In Serious Jeopardy

    11:55 a.m. Feb. 4, 2020

    - Seeking Alpha

  10. The Real Value Of A Breakthrough Therapy Designation

    9:30 a.m. Dec. 30, 2019

    - Seeking Alpha

  11. Marker Therapeutics: Promising Tech, Needs Better Execution

    2:43 p.m. Dec. 28, 2019

    - Seeking Alpha

  12. FCEL, I, SENS, RWLK and MRKR among midday movers

    1:26 p.m. Nov. 13, 2019

    - Seeking Alpha

  13. TSEM, VIPS among premarket losers

    10:14 a.m. Nov. 13, 2019

    - Seeking Alpha

  14. Marker Therapeutics down 16% premarket on delay in AML study

    8:59 a.m. Nov. 13, 2019

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/mrkr

Press Releases on MRKR

  1. Marker Therapeutics to Present at Two Upcoming Investor Conferences

    8:00 a.m. Feb. 18, 2020

    - PR Newswire - PRF

  2. Marker Therapeutics Announces Update to its Clinical Program in AML

    8:00 a.m. Feb. 11, 2020

    - PR Newswire - PRF

  3. Marker Therapeutics to Present at Two Upcoming Investor Conferences

    8:00 a.m. Nov. 25, 2019

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.